Description
An anticonvulsant; increases glucose, fructose-1,6-bisphosphate, and pyruvate levels in rat brain at 200 mg/kg; reduces the severity of audiogenic seizures in a rat model of barbiturate withdrawal-induced convulsions at 400 mg/kg; inhibits PTZ- or brainstem stimulation-induced tonic hindlimb extension (ED50s = 35 and 70 mg/kg, respectively), as well as leptazol-induced clonic seizures (ED50 = 230 mg/kg), in rats; reduces resting tremor by 60% in a macaque model of Parkinson’s disease induced by MPTP when administered at a dose of 150 mg/animal
Formal name: 3-ethyl-3-methyl-2,5-pyrrolidinedione
Synonyms: CI-366|NSC 64013
Molecular weight: 141.2
CAS: 77-67-8
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals||Research Area|Neuroscience|Behavioral Neuroscience|Addiction Research||Research Area|Neuroscience|Neurodegenerative Disorders|Parkinson’s Disease||Research Area|Neuroscience|Seizure Disorders